Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 plus fulvestrant vs placebo plus fulvestrant in HR+ HER2- advanced breast cancer
CTR20130871Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buparlisib in breast cancer, sponsored by Novartis. Started Jan 2015; status: completed.
02
Drugs
buparlisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20130871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130871.